-
Study aim
-
Determining and comparing the effect of two different doses of dexmedetomidine and propofol in sedation during surgery in patients undergoing ovarian puncture surgery
-
Design
-
A randomized, triple-blinding clinical trial, with the parallel groups, Phase 3 on 96 patients
-
Settings and conduct
-
In this three-blind randomized clinical trial study, 96 eligible patients referred to Isfahan Shahid Beheshti Hospital will be included and will be randomly divided into three groups. For patients in three groups, dexmedetomidine 0.5 and 1 μg/kg and propofol 50 μg/kg will be prescribed respectively. In this study, the patient, the researcher, and the statistical analyst will have no knowledge of the type of intervention. Then the degree of sedation and hemodynamic parameters of the patients will be evaluated between the three groups.
-
Participants/Inclusion and exclusion criteria
-
The inclusion criteria include infertile women candidates for puncture operation with IVF/ICSI indication, in the age group of 25 to 43 years, with ASA I or II, consent to enter the study. Exclusion criteria include having an allergy to any drug used, having a history of comorbidity.
-
Intervention groups
-
Control group: in this group, propofol induction of anesthesia 50 μg/kg per minute is prescribed.
First intervention group: In this group, dexmedetomidine bolus dose of 0.5 μg/kg is prescribed for induction of anesthesia, and dexmedetomidine dose of 0.5 μg/kg per minute is prescribed for anesthesia maintenance.
The second intervention group: In this group, a bolus dose of dexmedetomidine 1 μg/kg is prescribed for induction of anesthesia, and a dose of dexmedetomidine 1 μg/kg per minute is prescribed for anesthesia maintenance.
-
Main outcome variables
-
Heart rate; Systolic blood pressure; Diastolic blood pressure; Respiratory rate; Percentage of oxygen saturation; Degree of sedation